Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1950 of 6351
-
New study tests if trikafta helps CF patients breathe easier during exercise
Disease control Recruiting nowShortness of breath (dyspnea) during exercise is a major source of distress and is a commonly reported symptom in patients with cystic fibrosis (CF). A recent drug treatment option known as Trikafta, which contains elexacaftor, tezacaftor, and ivacaftor, may be used in patients w…
Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Blood markers could transform liver cancer surveillance
Knowledge-focused OngoingHepatocellular carcinoma (HCC) is the 4th most common cause of cancer death globally but only 20% are diagnosed in its early stages where curative treatment can be carried out. Current standard-of-care surveillance of patients at high risk of developing HCC with 6-monthly serum a…
Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New combo therapy shows promise in shrinking esophageal tumors before surgery
Disease control OngoingThis is an exploratory phase II clinical study designed to evaluate the safety and efficacy of Camrelizumab in combination with standard radiotherapy as preoperative neoadjuvant therapy for patients with resectable esophageal squamous cell carcinoma. In the study, all eligible su…
Phase 1/2 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New mRNA treatment for rare metabolic disease moves to Long-Term safety check
Disease control Recruiting nowThe main purpose of this study is to evaluate the long-term safety of mRNA-3927 administered to participants with propionic acidemia (PA) who have previously participated in Study mRNA-3927-P101 (NCT04159103).
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart rhythm crisis in sepsis: which strategy saves more lives?
Disease control Recruiting nowNew-onset supraventricular arrhythmia (NOSVA) is reported in 40 % of patients with septic shock and is associated with hemodynamic alterations and mortality. The lack of consensus regarding best practices for the management of NOSVA in this setting has led to major variations in …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Online program aims to stop postpartum depression before it starts
Prevention CompletedWomen's perinatal mental health problems can create a cascade of short- and long-term negative influences for the mother, child, and the family as a whole. To prevent these impacts, preventive online and telephone interventions exist, but need to be tested and improved to develop…
Sponsor: St. Justine's Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Can a common gout pill help fight Obesity-Related health problems?
Disease control CompletedBackground: About 40 percent of adults and 20 percent of adolescents in the U.S. have a body mass index over 30 kg/m2. Being overweight may lead to a state of low-level inflammation. This may cause health problems. Researchers want to see if an anti-inflammatory medicine can hel…
Phase 2 • Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Disease control
Last updated Jun 26, 2026 14:00 UTC
-
New combo therapy for CLL shows promise in small japanese study
Disease control CompletedChronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries, representing approximately 30% of all adult leukemias. There is a large difference in proportion of malignant lymphoma between the United States (US) and Japan was seen in CLL/small lymphocytic l…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New online tool aims to help teens breathe easier
Disease control OngoingThis study will test the efficacy and cost-effectiveness of Controlling Asthma Program for Adolescents (CAMP Air), an e-health intervention, among urban predominately Black and Hispanic adolescents with uncontrolled asthma. It will also examine barriers and facilitators to adopti…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for young cancer patients: experimental drug targets recurrent tumors
Disease control Recruiting nowThis phase I/II trial evaluates the highest safe dose, side effects, and possible benefits of tegavivint in treating patients with solid tumors that has come back (recurrent) or does not respond to treatment (refractory). Tegavivint interferes with the binding of beta-catenin to …
Phase 1/2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Protein fingerprints may spot hidden transplant rejection
Diagnosis CompletedMicrovascular inflammation, the hallmark histological criteria of antibody-mediated rejection in kidney transplantation, remains an issue in routine practice, due to a lack of reproducibility in its recognition by pathologists and an incomplete comprehension of its pathophysiolog…
Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New blood test aims to catch liver cancer recurrence early
Diagnosis OngoingThis study explores the potential values of a new blood test approach to detect measurable residual disease or early coming back of cancer (recurrence)/cancer growing, spreading, or getting worse (progression) in patients with liver cancer that can be removed by surgery (resectab…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New shot could help when blood pressure pills Aren't enough
Disease control CompletedThe purpose of this study is to evaluate the effect of zilebesiran on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of zilebesiran as add-on therapy.
Phase 2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Brain zaps may sharpen memory in early schizophrenia
Symptom relief Recruiting nowThis study will investigate the effects of intermittent Theta Burst Stimulation (iTBS) on natural oscillatory frequency of the dorsolateral prefrontal cortex (DLPFC) and working memory in early-course schizophrenia (EC-SCZ). Transcranial magnetic stimulation (TMS) will be used to…
Sponsor: Fabio Ferrarelli • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New hope for teens with severe asthma? dupilumab under the microscope
Disease control CompletedPrimary objective: \- Describe the characteristics of enrolled severe asthma patients Secondary objectives: * Assess the control of asthma under dupilumab (Dupixent®) treatment until 1 year * Assess the clinical objectives of the asthma care * Assess comorbidities associated w…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Why does cervical cancer persist despite prevention tools? a study seeks answers
Knowledge-focused OngoingA portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of effective preventive tools. A better understanding of the current situation of this scenario will provid…
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
HPV Vaccine's Long-Term power tested in rwandan women
Knowledge-focused CompletedOur study will assess and measure population effectiveness of prophylactic HPV vaccine in reducing cervical, anal, and/or oral prevalent and 6-month persistent infections among HPV-vaccinated and 757 HPV-unvaccinated Rwandan WLWH aged 18-26 years. Additional objectives include th…
Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Could a cooling sleeve protect nerves during chemo?
Symptom relief CompletedThe study aims to investigate the safety and tolerability of limb cryocompression in preventing of Chemotherapy-induced Peripheral Neuropathy via a newly developed limb cryocompression device in healthy subjects and cancer patients. The limb cryocompression device will be tested …
Sponsor: National University Hospital, Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Laser or cream? new study tests best treatment for lichen sclerosus
Disease control CompletedLichen sclerosus (LS) is a common autoimmune disease of the genital skin. It affects 1/900 women with an age peak in the sixth decade of life and is manifested by chronic inflammation of the genital, perineal, and perianal areas associated with itching, burning, pain, and sorenes…
Phase 3 • Sponsor: Ruhr University of Bochum • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New vaccine aims to fight hidden virus in people with HIV
Vaccine CompletedA5355 was a randomized, placebo-controlled study conducted at US sites to evaluate the safety and immunogenicity of two injections of the study drug Modified Vaccinia Ankara (MVA)-based anti-Cytomegalovirus (CMV) Vaccine (Triplex®) in adults with both HIV and CMV. Participants we…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:33 UTC